Second-line real-world treatment patterns and outcomes in patients with advanced/metastatic non-small cell lung cancer treated with first line immuno-oncology monotherapy (ESMO 2019, 2019)

(untitled) - Talbot, D; Fish, SM; Ong, TJ; Flick, DE